Boston Scientific Corporation (BIT:1BSX)

Market Cap	130.28B
Revenue (ttm)	15.75B
Net Income (ttm)	2.13B
Shares Out	n/a
EPS (ttm)	1.43
PE Ratio	61.08
Forward PE	32.73
Dividend	n/a
Ex-Dividend Date	n/a

Volume	46
Average Volume	97
Open	89.00
Previous Close	88.40
Day's Range	88.80 - 89.00
52-Week Range	68.00 - 103.00
Beta	n/a
RSI	38.60
Earnings Date	Jul 23, 2025

About Veren

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1979
• Employees: 53,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1BSX

Financial Performance

In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.

Financial numbers in CAD